ArticleQuantitative imaging in medicine and surgery2026
The value of dual-layer detector spectral CT multiparameter imaging in distinguishing between benign lesions and carcinomas of the larynx and hypopharynx.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Accurately distinguishing between benign and malignant lesions in the larynx and hypopharynx is crucial for formulating individualized and precise treatment plans. Due to the low soft-tissue resolution of conventional computed tomography (CT), the diagnostic accuracy of laryngeal and hypopharyngeal lesions is not satisfactory in clinical practice. Therefore, this study aimed to assess the value of dual-layer detector spectral computed tomography (DLSCT) multiparameter imaging for distinguishing between laryngeal and hypopharyngeal benign lesions (LHBLs) and laryngeal and hypopharyngeal carcinomas (LHCs) and to identify the optimal DLSCT parameters. Methods: The data of 141 patients were retrospectively analyzed. Spectral CT parameters, including those derived from the arterial phase (AP) and venous phase (VP), as well as the maximum lesion diameter (MLD), were measured and analyzed. The diagnostic performance of each spectral parameter was evaluated using receiver operating characteristic (ROC) curve analysis and the area under the curve (AUC). The DeLong test was then used to compare differences in diagnostic performance. The parameters demonstrating the highest AUC in the AP and VP were integrated via logistic regression. Clinical utility was assessed by decision curve analysis (DCA). Results: With the exception of the virtual non-contrast CT values in the AP and the standardized effective atomic number (sZeff) in both the VP and AP, all the measured spectral CT parameters differed significantly between the LHBLs and LHCs (P<0.002). Among all the single parameters analyzed, the 40-kiloelectron volt (keV) virtual monochromatic image (VMI) in the VP achieved the highest AUC of 0.932, which was significantly higher than that of the conventional image (CI) (P<0.05). The AUC values for the CIs in the AP and VP were 0.837 and 0.866, respectively. When the 40 keV-AP VMI, 40 keV-VP VMI, and MLD were combined in a model, the AUC increased to 0.970, which was significantly higher than the AUC of the model that combined the 40 keV-AP VMI and MLD (P=0.009), but did not differ significantly from the AUC of the model that combined the 40 keV-VP VMI and MLD (P=0.403). The model that combined the 40 keV-AP VMI, 40 keV-VP VMI, and MLD had the greatest net clinical benefit, but it was only superior to the model that combined the 40 keV-VP VMI and MLD within certain risk threshold ranges. Conclusions: DLSCT exhibited better diagnostic performance for distinguishing between LHBLs and LHCs than conventional CT. Notably, 40 keV-VP VMI demonstrated favorable diagnostic value and may serve as a potential auxiliary imaging tool for this differential diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.